BeOne Medicines
Jay Seemann has extensive experience in the pharmaceutical industry, primarily in market access and value roles. Jay is currently working at BeiGene as the Global Vice President of Market Access & Value. Prior to that, they were the Global Vice President of Commercial Diagnostics at NanoString Technologies, Inc. from 2014 to 2019. From 2008 to 2013, they served as the Senior Director of US Market Access & Value at Onyx Pharmaceuticals. Before that, they worked at Bayer Pharmaceuticals as the Director of Market Access - US, overseeing the pricing, reimbursement, access, and trade functions. Jay also held the position of Director of National Accounts at Sanofi Aventis. Jay Seemann has a proven track record of successful product launches and restructuring departments to improve market access.
From 1986 to 1991, Jay Seemann pursued their Bachelor of Science degree in Sales, Distribution, and Marketing Operations at Ball State University - Miller College of Business.
This person is not in any offices
BeOne Medicines
33 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.